ONLINE:
Biology Strategy Meeting
Following fantastic feedback we’re thrilled to announce we will be running another Online Biology Strategy Meeting. This virtual conference format allows you to discuss key Biology issues with your peers and forge new connections from the comfort of your own home.
Dates
12 Nov, 2020What makes our online strategy meeting unique?
No other event creates such a unique and personalised event experience. From the tailored agenda, to the senior delegation; our online strategy meetings provide the perfect learning and networking environment from the comfort of your own home or office.
Roundtable Discussions
Intimate discussions leads by a renowned experts. Have your voice heard alongside like-minded life science executives.
Intimate discussions leads by a renowned experts. Have your voice heard alongside like-minded life science executives.
Global Networking
With senior delegation from big pharma and innovative biotech from all over the globe, you can network with peers from different locations, all in one place.
With senior delegation from big pharma and innovative biotech from all over the globe, you can network with peers from different locations, all in one place.
Personalised Agenda
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.
Totally Online Format
It’s more important than ever to boost collaboration while promoting safety & accessibility. That’s exactly what you can expect from our online format.
It’s more important than ever to boost collaboration while promoting safety & accessibility. That’s exactly what you can expect from our online format.
Meet the Facilitators
Our panel of facilitators play a key role in shaping the agenda. See who will be bringing their expertise to the November Strategy Meeting:
Marcie Glicksman
Vice President, Biology Enclear Therapies
Bill Farley
VP Sorrento Therapeutics
Lassina Badolo
Executive Director – Head of DMPK, Early Respiratory & Immunology AstraZeneca
Jon Moore
CEO Pheno Therapeutics
Maria Flocco
VP, Global Head of Structure, Biophysics & Fragment-Based Lead Generation AstraZeneca
Klaus Dembowsky
Chief Executive Officer AMCURE GmbH
Marie-Claire Peakman
Executive Director Pfizer
Yohann Potier
Head of Genetics Vanda Pharmaceuticals
Asif Ahmed
Executive Chairman and CEO MirZyme TherapeuticsReasons to Attend the Virtual Strategy Meeting
Fully Interactive Virtual Conference
We’re all bored of the same webinar format by now. Instead, join intimate groups of like-minded professionals and discuss the topics that really matter to you
Personalised and Easy to Join Agenda
Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we will send you the direct links and calendar reminder to join
Senior Decision Makers
All our roundtable discussions are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard
Private and Intimate Discussions
Each sessions is read by an industry expert and the roundtables are limited to ensure you have fruitful and genuine conversations with your colleagues
Agenda
IN SILICO BIOLOGY & INFORMATICS – Evolving with the digital era: How the landscape of preclinical biology is changing and will change with innovations in computational biology
DMPK & ADME – Innovations in Technology – Optimising DMPK with AI and in silico Simulations
IN VIVO & IN VITRO PHARMACOLOGY – Outsourcing in vivo and in vitro experiments – comparative analysis of vendors in regards to price, location, capabilities and characteristics
STRUCTURAL BIOLOGY & BIOPHYSICS – Biophysics in drug discovery: impact, challenges and
opportunities
STRATEGIC PARTNERSHIP & OUTSOURCING – When? Where? How? – Best Outsourcing Practices and Strategies
TARGET VALIDATION – Strategies to ensure effective target validation to mitigate the lack efficacy in humans for oncological therapeutics
IN SILICO BIOLOGY & INFORMATICS – TBC
DMPK & ADME – Overcoming costly attrition through improved ADME evaluation
IN VIVO & IN VITRO PHARMACOLOGY – Better understanding DDIs for nonCYP enzymes to avoid unnecessary DDI trials
STRUCTURAL BIOLOGY & BIOPHYSICS – Best biophysical techniques to accelerate and deepen the understanding of ligand interactions with biological target
STRATEGIC PARTNERSHIP & OUTSOURCING – TBC
TARGET VALIDATION – TBC
IN SILICO BIOLOGY & INFORMATICS – Using Digital Laboratory Informatics to create compliant and efficient lab workflows
DMPK & ADME – Improving non-clinical GLP toxicology studies to reduce failed candidates
IN VIVO & IN VITRO PHARMACOLOGY – Accurately translating in vitro data to correlate with in vivo animal and human models
STRUCTURAL BIOLOGY & BIOPHYSICS – Investigating energetics and thermodynamics of biomolecular interactions with very high precision
STRATEGIC PARTNERSHIP & OUTSOURCING – Communication is key – effective vendor oversight strategies
TARGET VALIDATION – Effectively utilising in silico simulations and modelling technologiex to increase target validation success and improve efficacy in clinical trials
See what’s next
Check out the full agenda from the 2020 Strategy Meeting, or find out more about upcoming events.
Thought Leader
Co-Hosts
Pro-partners
Payment Securely powered by stripe
